Table 3 The effects of the lifestyle intervention compared with the control condition at months 7-12 of follow-up.

BMI (kg/m2)

134

Baseline

30.36 (4.93)

29.54 (5.08)

7-12 months

30.29 (5.08)

29.51 (5.18)

0.27 (-0.60 to 1.14)

0.56

Exercise level (1-4)*

107

Baseline

2.48 (0.60)

2.48 (0.71)

7-12 months

2.22 (0.86)

2.27 (0.81)

-0.14 (-0.27 to 0.01)

0.12

Fasting glucose (mmol/l)

170

Baseline

7.21 (1.36)

7.28 (2.05)

7-12 months

7.07 (1.25)

7.17 (1.67)

0.08 (-0.11 to 0.26)

0.48

HbA1c (%)

94

Baseline

6.73 (0.92)

6.66 (0.97)

7-12 months

6.72 (0.83)

6.74 (0.90)

-0.10 (-0.23 to 0.03)

0.26

Blood pressure

Systolic (mmHg)

166

Baseline

138.98 (16.64)

143.68 (17.41)

7-12 months

139.47 (16.55)

142.58 (17.47)

-1.49 (-4.04 to 1.05)

0.73

Diastolic (mmHg)

165

Baseline

79.88 (8.31)

79.39 (8.79)

7-12 months

78.71 (8.18)

78.53 (9.20)

-0.58 (-1.82 to 0.66)

0.40

Total cholesterol (mmol/l)

97

Baseline

4.54 (0.94)

4.56 (1.00)

7-12 months

4.56 (1.12)

4.52 (1.01)

-0.02 (-0.18 to 0.14)

0.87

LDL (mmol/l)

97

Baseline

2.80 (0.76)

2.85 (1.04)

7-12 months

2.74 (0.92)

2.72 (0.85)

0.10 (-0.04 to 0.23)

0.34

HDL (mmol/l)

97

Baseline

1.16 (0.29)

1.16 (0.28)

7-12 months

1.18 (0.28)

1.18 (0.29)

0.00 (-0.05 to 0.05)

0.96

Triglycerides (mmol/l)

97

Baseline

1.73 (0.98)

1.63 (0.95)

7-12 months

1.83 (0.95)

1.76 (1.48)

-0.20 (-0.37 to 0.03)

0.11